Advertisement
About Sequenom
Sequenom is committed to providing the best genetic analysis products forresearch and the molecular diagnostic markets. The Company makes availablesuperior solutions for genomic science in biomedical research, livestock andagricultural applications and molecular medicine, as well as for variousdiagnostic markets, including noninvasive prenatal testing, oncology andinfectious diseases. Sequenom's proprietary MassARRAY(R) system deliversreliable and specific data from complex biological samples and from genetictarget materials available only in trace amounts.
Advertisement
Minimum Requirements to listen to broadcast:
The Windows Media Player software, downloadable free fromhttp://www.microsoft.com and at least a 56Kbps connection to the Internet. Ifyou experience problems listening to the webcast, send an E-mail to:[email protected]: Sequenom: The Future of Noninvasive Prenatal Diagnostics When: Tuesday, June 3, 2008 at 6:00 p.m. Pacific time Where: www.sequenom.com Agenda: Hosted by: Harry Stylli, Ph.D., Chief Executive Officer of Sequenom, Inc. Presenters: Jacob Canick, Ph.D., Professor of Pathology and Laboratory Medicine Brown University Medical School "Methods for screening pregnancies for Down syndrome" Allan T. Bombard, MD, FACOG, FACS, FACMG, Chief Medical Officer, Sharp Mary Birch Hospital; Adjunct Professor, Obstetrics and Gynecology/SUNY Downstate Medical Center; Clinical Professor, Albert Einstein College of Medicine "Current clinical practice for Down syndrome screening and diagnosis" Betty Dragon, Ph.D., Senior Vice President, Research & Development of Sequenom, Inc. "Sequenom's SEQureDx: A noninvasive prenatal diagnostic test for Down syndrome. Technical Achievements, Milestones and Future Challenges" Dennis Lo, Consultant to Sequenom, Inc. "The future of prenatal diagnosis: Progress through fetal nucleic acids" How: Live over the Internet - Simply log on to the web at the address above. Presentation will be archived. Contact: Lippert/Heilshorn & Associates Jody Cain ([email protected]) 310-691-7100
SOURCE Sequenom, Inc.
